Pharma Mar (MEX:PHM1N) E10: MXN37.17 (As of Mar. 2026)


MEX:PHM1N Pharma Mar SA MEX:PHM1N
86 GF Score
Price MXN1,608.38
GF Value MXN1,937.69
! 3 Warning Signs
View Full Analysis

What is Pharma Mar E10?

Pharma Mar MEX:PHM1N 86 E10 is MXN37.17 as of Mar. 2026. GuruFocus rates MEX:PHM1N with a GF Score™ of 86/100 and a GF Value™ of MXN1,937.69. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pharma Mar's adjusted earnings per share data for the three months ended in Mar. 2026 was MXN1.847. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN37.17 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Pharma Mar's average E10 Growth Rate was 34.70% per year. During the past 3 years, the average E10 Growth Rate was 10.60% per year. During the past 5 years, the average E10 Growth Rate was 22.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pharma Mar was 35.90% per year. The lowest was 10.60% per year. And the median was 15.10% per year.

As of today (2026-06-26), Pharma Mar's current stock price is MXN1608.38. Pharma Mar's E10 for the quarter that ended in Mar. 2026 was MXN37.17. Pharma Mar's Shiller PE Ratio of today is 43.27.

During the past 13 years, the highest Shiller PE Ratio of Pharma Mar was 541.41. The lowest was 19.44. And the median was 49.07.


Pharma Mar  (MEX:PHM1N) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pharma Mar's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1608.38/37.17
=43.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Pharma Mar was 541.41. The lowest was 19.44. And the median was 49.07.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pharma Mar E10 Related Terms


Pharma Mar E10 Historical Data

* Premium members only.

The historical data trend for Pharma Mar's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar E10 Chart

Pharma Mar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.16 36.27 55.99 31.24 42.09

Pharma Mar Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.71 33.79 28.57 42.09 37.17

MEX:PHM1N vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Pharma Mar's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Shiller PE Ratio falls into.


MEX:PHM1N
86GF Score
Pharma Mar SA MEX:PHM1N
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Mar E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharma Mar's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.847/128.4016*128.4016
=1.847

Current CPI (Mar. 2026) = 128.4016.

Pharma Mar Quarterly Data

per share eps CPI Adj_EPS
201606 -6.811 100.333 -8.716
201609 -4.010 99.737 -5.163
201612 -8.849 101.842 -11.157
201703 -2.690 100.896 -3.423
201706 -5.495 101.848 -6.928
201709 -8.250 101.524 -10.434
201712 -15.477 102.975 -19.299
201803 -1.597 102.122 -2.008
201806 5.434 104.165 6.698
201809 -4.935 103.818 -6.104
201812 -5.353 104.193 -6.597
201903 -12.443 103.488 -15.439
201906 -12.757 104.612 -15.658
201909 -6.662 103.905 -8.233
201912 17.666 105.015 21.600
202003 98.856 103.469 122.677
202006 61.170 104.254 75.338
202009 24.771 103.521 30.725
202012 8.242 104.456 10.131
202103 32.417 104.857 39.696
202106 25.139 107.102 30.138
202109 15.323 107.669 18.274
202112 49.110 111.298 56.657
202203 26.755 115.153 29.833
202206 15.221 118.044 16.557
202209 9.297 117.221 10.184
202212 6.827 117.650 7.451
202303 1.515 118.948 1.635
202306 5.191 120.278 5.542
202309 1.589 121.343 1.681
202312 -7.156 121.300 -7.575
202403 2.370 122.762 2.479
202406 1.391 124.409 1.436
202409 4.910 123.121 5.121
202412 28.066 124.753 28.887
202503 -4.990 125.531 -5.104
202506 29.115 127.251 29.378
202509 -5.140 126.842 -5.203
202512 67.485 128.402 67.485
202603 1.847 128.402 1.847

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN37.17 mean?
Pharma Mar (MEX:PHM1N) has a E10 of MXN37.17 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pharma Mar and its competitors.
Is Pharma Mar's E10 too high?
Pharma Mar's current E10 is MXN37.17. Overall, Pharma Mar has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Pharma Mar's E10 compare to VRTX and REGN?
Pharma Mar's E10 of MXN37.17 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pharma Mar and its competitors. Pharma Mar's current E10 is MXN37.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Mar stock overvalued right now?
Pharma Mar (MEX:PHM1N) has a current E10 of MXN37.17. The stock's GF Value™ is MXN1,937.69, compared to a current price of MXN1,608.38 — trading 17% below its estimated fair value. The current E10 is MXN37.17. Pharma Mar's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Pharma Mar (MEX:PHM1N), the current E10 is MXN37.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Mar (MEX:PHM1N) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of MXN1,608.38 is trading 17% below its estimated GF Value™ of MXN1,937.69.

Key valuation signals for MEX:PHM1N:

  • E10: MXN37.17
  • GF Value™: MXN1,937.69 vs. price of MXN1,608.38 (17% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the MEX:PHM1N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
86GF Score

Get the complete analysis for MEX:PHM1N

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,608.38
Price
MXN1,937.69
GF Value